Drew Rowan

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£843,028

Dec 11 - Feb 14

Target validation and lead identification for the development of disease modifying drugs in osteoarthritis (OA)

MRC award to Newcastle University and Drew Rowan

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}